Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 728)
Posted On: 03/15/2021 9:04:08 AM
Post# of 154993
Avatar
Posted By: TechGuru
Have received some inquiries regarding the Power we obtained in the Length Hospital Stay for Ordinal-2 (mITT).

As we know we had only 62 patients in this group and got an overall p-value of 0.005.

If we assume once more mean of 38.5 days for placebo with an overall SD of +-10 we obtain that, the achieved power of our "trial" (for O-2 Critical patients) was app. 58.4 % (due to the reduced number of patients, 62).

FDA normally requires 80%-90% for approval but I assure you it has issued EUA for results with much less indication of efficacy.

Leronlimab's is all over the place, sure is "only" 62 patients, sure, it helps the mostly critical patients, but .... every single measurement showed some improvement ...

Look at the charts below ... every single one of them ....

1137972895_ScreenHunter_660Mar.1508.51.jpg
1924957169_ScreenHunter_662Mar.1508.52.jpg
1366913706_ScreenHunter_663Mar.1508.52.jpg
616816017_ScreenHunter_664Mar.1508.52.jpg
695899078_ScreenHunter_665Mar.1508.52.jpg

Question: if a drug is demonstrably SAFE and it improves COVID patients, why not allow it ???

I don't have a good answer .... not after witnessing what "they" did with other companies whose names I don't want to mention













(29)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site